Prophylactic ECMO Support during Elective Coronary Percutaneous Interventions in High-Risk Patients: A Single-Center Experience

Table 1

Baseline clinical characteristics.

Patient	Age (years)	Males	BMI (kg/m^2)	Risk factors	KD	ACS	Pulmonary edema at admission	Cardiogenic shock at admission	Congestive heart failure	Previous stroke
1	67	1	25.6	H HT T PAD	1	UA	1	0	0	0
2	76	1	27.1	HT T	0	NSTEMI	1	C	0	0
3	74	1	22.3	H HT T	1	NSTEMI	1	B	0	0
4	70	1	28	D H HT T PAD	1	0	0	0	1	0
5	74	1	27	H HT T PAD	0	NSTEMI	0	0	1	0
6	61	1	22.3	H HT T	1	NSTEMI	0	0	1	0
7	63	1	26.3	H HT T	1	0	0	0	1	0
8	74	1	22.4	H HT T	0	NSTEMI	0	A	1	0
9	66	1	26	H HT T PAD	0	0	1	0	1	0

BMI: body mass index; risk factors (diabetic (D) hypertension (H)/hypercholesterolaemia (HT)/tobacco abuse (T)/peripheral artery disease (PAD)); KD: kidney disease; impaired renal function (eGFR < 60, stage ≥ 3); ACS: acute coronary syndrome; UA: unstable angina; NSTEMI: non-ST-elevation myocardial infarction; cardiogenic shock stages: A, B, C, D, and E (SCAI definition).